Reach Us +44-1522-440391
Editor - Paramjot Kaur | Nova Southeastern University | 26774

Journal of Oncology Research and Treatment
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Paramjot Kaur

Paramjot Kaur
Paramjot Kaur Research Associate, Rumbaugh-Goodwin Institute for Cancer Research Nova Southeastern University, USA. (August  2016 – At present) St. Matthew’s University, School of Medicine, Cayman Islands (MD, 2010), Purdue University Global, USA (MPH, 2015) Address: 3321, South University Drive, CCR 6th floor, Fort Lauderdale, Florida – 33314, USA,  


Paramjot Kaur is  passionate about making a positive difference to the local and global community with my well rounded experience in a variety of healthcare settings and diverse populations. I am highly dedicated and driven with strong work ethics to maintain the high professional standards. Professional expertise demonstrated in the following areas: Public Health; Epidemiology; Scientific research; Cancer biology; Health education; Preventive care; Data analysis: PRISM, SPSS and ImageJ; Research lab techniques, Laboratory skills; Research reports, study protocols and abstracts from data collected and analyzed; Patient care, interpersonal and customer service skills; Grant writing and administrative support; Budgeting/cost reduction/fund raising; Project management/leadership; Computer skills including MS Office, Excel, and PowerPoint.

Research Interest

Research Interest: Cancer prevention, drug discovery, diagnostic biomarkers and related pathways as interventional targets for cancer prevention/treatment, testing the efficacy of natural products and therapeutic molecules against chemo-induced peripheral neuropathy in Multiple Myeloma, in vitro as well as in vivo studies, evidence based medicine and population health.

Leave Your Message 24x7